United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints
Go back to United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 547.25 -8.66 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $555.91 | 52 Week High | $164.04 | |||
| Open | $556.31 | 52 Week Low | $97.52 | |||
| Day High | $556.45 | P/E | 100.05 | |||
| Day Low | $543.82 | EPS | $5.47 | |||
| Volume | 314,688 | |||||
